Canaccord Genuity Maintains Buy on Merit Medical Systems, Raises Price Target to $112
Canaccord Genuity Maintains Buy on Merit Medical Systems, Raises Price Target to $112
Canaccord Genuity維持對Merit醫療系統的買入，將目標股價上調至112美元
Canaccord Genuity analyst Jon Young maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and raises the price target from $102 to $112.
Canaccord Genuity分析師喬恩·楊維持Merit Medical Systems（納斯達克股票代碼：MMSI）的買入並將目標股價從102美元上調至112美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。